BioNTech (NASDAQ:BNTX) Now Covered by Analysts at Citigroup
Citigroup started coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $145.00 target ...
BioNTech SE (BNTX) Gets a Buy from Deutsche Bank
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...
Investopedia6d
BioNTech Stock Drops as Sales Outlook Disappoints
U.S.-listed shares of BioNTech fell Monday, as the COVID-19 vaccine maker’s soft sales outlook offset better-than-expected quarterly results. The German company said it expects 2025 total ...
The Motley Fool6d
BioNTech Surpasses Q4 Revenue Estimates
BioNTech's Q4 2024 revenue surpassed estimates, totaling 1.19 billion euros. EPS reached 1.08 euros, vastly exceeding the expected 0.42 euros, showcasing strong earnings management. Revenue from ...
Reuters11d
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
DUESSELDORF, Germany, March 5 (Reuters) - A German court on Wednesday ruled that Pfizer (PFE.N), opens new tab and its partner BioNTech (22UAy.DE), opens new tab violated a COVID-19 vaccine patent ...
ETF Daily News4d
BioNTech (NASDAQ:BNTX) Shares Down 6.4% Following Analyst Downgrade
BioNTech traded as low as $98.25 and last traded at $98.61. Approximately 739,834 shares traded hands during trading, a decline of 6% from the average daily volume of 787,574 shares. The stock had ...
UBS Sticks to Their Hold Rating for BioNTech SE (BNTX)
In a report released today, Eliana Merle from UBS maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price target of ...
Nasdaq4d
4 Analysts Have This To Say About BioNTech
In the last three months, 4 analysts have published ratings on BioNTech (NASDAQ:BNTX), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary ...
Seeking Alpha6d
BioNTech SE (BNTX) Q4 2024 Earnings Call Transcript
Welcome to BioNTech's Fourth Quarter and Full-Year 2024 Earnings Call. I would like to hand the call over to Michael Horowicz, Director of Investor Relations. Please go ahead. Thank you.
Benzinga.com6d
Pfizer's COVID-19 Shot Partner BioNTech Reports Q4 Profit, But 2025 Guidance Falls Short On Expectations
BioNTech reported Q4 earnings of €1.08 per share, beating the €0.38 consensus but down from €1.88 last year. 2025 revenue guidance of €1.7B-€2.2B trails the €2.57B consensus. Get 5 ...
Yahoo Finance1mon
What Makes BioNTech (BNTX) a New Buy Stock
Investors might want to bet on BioNTech SE Sponsored ADR (BNTX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...